150 related articles for article (PubMed ID: 23235193)
1. Update on early cardiovascular and metabolic risk factors in children and adolescents affected with growth hormone deficiency.
Capalbo D; Esposito A; Di Mase R; Barbieri F; Parenti G; Vajro P; Pignata C; Salerno M
Minerva Endocrinol; 2012 Dec; 37(4):379-89. PubMed ID: 23235193
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone and the cardiovascular system.
Palmeiro CR; Anand R; Dardi IK; Balasubramaniyam N; Schwarcz MD; Weiss IA
Cardiol Rev; 2012; 20(4):197-207. PubMed ID: 22314142
[TBL] [Abstract][Full Text] [Related]
3. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular alterations in adult GH deficiency.
Di Somma C; Scarano E; Savastano S; Savanelli MC; Pivonello R; Colao A
Best Pract Res Clin Endocrinol Metab; 2017 Feb; 31(1):25-34. PubMed ID: 28477729
[TBL] [Abstract][Full Text] [Related]
5. Alterations in body composition and fat distribution in growth hormone-deficient prepubertal children during growth hormone therapy.
Roemmich JN; Huerta MG; Sundaresan SM; Rogol AD
Metabolism; 2001 May; 50(5):537-47. PubMed ID: 11319714
[TBL] [Abstract][Full Text] [Related]
6. Insulin sensitivity in growth hormone (GH)-deficient adults and effect of GH replacement therapy.
Alford FP; Hew FL; Christopher MC; Rantzau C
J Endocrinol Invest; 1999; 22(5 Suppl):28-32. PubMed ID: 10442567
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular disease and risk factors: the role of growth hormone.
Isgaard J
Horm Res; 2004; 62 Suppl 4():31-8. PubMed ID: 15591764
[TBL] [Abstract][Full Text] [Related]
8. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH--an update.
Gazzaruso C; Gola M; Karamouzis I; Giubbini R; Giustina A
J Clin Endocrinol Metab; 2014 Jan; 99(1):18-29. PubMed ID: 24217903
[TBL] [Abstract][Full Text] [Related]
10. Continuation of growth hormone therapy versus placebo in transition-phase patients with growth hormone deficiency: impact on body composition, insulin sensitivity, and thyroid function.
Jørgensen JO; Nørrelund H; Vahl N; Juul A; Skakkebaek NE; Christiansen JS
J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1355-60. PubMed ID: 12510991
[TBL] [Abstract][Full Text] [Related]
11. [Homocysteine levels in growth hormone deficient children and adolescents before and after one year of recombinant human growth hormone (GH) replacement therapy].
Szczepańska J; Urban M; Głowińska B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):87-92. PubMed ID: 15504311
[TBL] [Abstract][Full Text] [Related]
12. Beginning to end: cardiovascular implications of growth hormone (GH) deficiency and GH therapy.
Colao A; Di Somma C; Savanelli MC; De Leo M; Lombardi G
Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S41-8. PubMed ID: 16690338
[TBL] [Abstract][Full Text] [Related]
13. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M
Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
[TBL] [Abstract][Full Text] [Related]
14. Comparison of glucose and lipid metabolism and bone mineralization in patients with growth hormone deficiency with and without long-term growth hormone replacement.
Roemmler J; Kuenkler M; Schneider HJ; Dieterle C; Schopohl J
Metabolism; 2010 Mar; 59(3):350-8. PubMed ID: 19800640
[TBL] [Abstract][Full Text] [Related]
15. Changes in body composition during 12 months after discontinuation of growth hormone therapy in young adults with growth hormone deficiency from childhood.
Stouthart PJ; de Ridder CM; Rekers-Mombarg LT; van der Waal HA
J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():335-8. PubMed ID: 10698598
[TBL] [Abstract][Full Text] [Related]
16. Postprandial triglyceride profile after a standardized oral fat load is altered in growth hormone (GH)-deficient adult patients and is not improved after short-term GH replacement therapy.
Perotti M; Caumo A; Brunani A; Cambiaghi N; Casati M; Scacchi M; Perra S; Rocco C; Mancia G; Grassi G; Cavagnini F; Pincelli AI
Clin Endocrinol (Oxf); 2012 Nov; 77(5):721-7. PubMed ID: 22519803
[TBL] [Abstract][Full Text] [Related]
17. Cross-sectional and prospective study of the effects of GH therapy on metabolic panel in children with GH deficiency.
Ramistella V; Wasniewska M; Arasi S; Catena M; Velletri MR; Corica D; Santucci S; De Luca F
Pediatr Med Chir; 2014 Dec; 36(5-6):104. PubMed ID: 25669895
[TBL] [Abstract][Full Text] [Related]
18. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
[TBL] [Abstract][Full Text] [Related]
19. Role of growth hormone in chronic heart failure: therapeutic implications.
Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
[TBL] [Abstract][Full Text] [Related]
20. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
